AIS Healthcare Acquires Ophthalmology Compounding Pharmacy Hunt Valley PharmaLAB

DALLAS--(BUSINESS WIRE)--AIS Healthcare has announced the acquisition of Hunt Valley PharmaLAB (“Hunt Valley”), a 503A compounding pharmacy focused on ophthalmology medications. Already the leading targeted drug delivery (TDD) and infusion care provider, AIS Healthcare will now be able to provide high-quality, custom ophthalmology prescriptions to patients across the country. “As the nation’s leading 503A compounding pharmacy, AIS Healthcare is proud to have set new quality standards for patien

Full Story →